Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017006
Filing Date
2022-11-09
Accepted
2022-11-09 07:15:44
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q trvn-20220930x10q.htm   iXBRL 10-Q 1812078
2 EX-31.1 trvn-20220930xex31d1.htm EX-31.1 16920
3 EX-31.2 trvn-20220930xex31d2.htm EX-31.2 16050
4 EX-32.1 trvn-20220930xex32d1.htm EX-32.1 8919
5 EX-32.2 trvn-20220930xex32d2.htm EX-32.2 9263
  Complete submission text file 0001558370-22-017006.txt   7803594

Data Files

Seq Description Document Type Size
6 EX-101.SCH trvn-20220930.xsd EX-101.SCH 53110
7 EX-101.CAL trvn-20220930_cal.xml EX-101.CAL 60505
8 EX-101.DEF trvn-20220930_def.xml EX-101.DEF 227632
9 EX-101.LAB trvn-20220930_lab.xml EX-101.LAB 520243
10 EX-101.PRE trvn-20220930_pre.xml EX-101.PRE 384733
59 EXTRACTED XBRL INSTANCE DOCUMENT trvn-20220930x10q_htm.xml XML 1425085
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36193 | Film No.: 221370643
SIC: 2834 Pharmaceutical Preparations